Skip to main content
Top
Published in: Clinical Rheumatology 2/2019

01-02-2019 | Original Article

Prevalence and frequency of self-perceived systemic features in people with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type

Authors: Cliffton Chan, Anne Krahe, Yim Tang Lee, Leslie L. Nicholson

Published in: Clinical Rheumatology | Issue 2/2019

Login to get access

Abstract

Some commonly reported systemic features of joint hypermobility syndrome (JHS)/Ehlers-Danlos syndrome hypermobility type (EDS-HT) are absent from nosologies due to insufficient validity. The primary aim was to examine the hypothesised high prevalence and frequency of orthostatic intolerance, easy bruising, and urinary incontinence in adults with JHS/EDS-HT and secondarily to determine the association between extent of generalised joint hypermobility (GJH) and these systemic features. A cross-sectional cohort study was conducted via online recruitment of medically diagnosed JHS/EDS-HT patients. A survey collected demographic data and clinical history. A subgroup of participants underwent physical testing of GJH using the Beighton score and Lower Limb Assessment Score (LLAS). Descriptive analysis was performed on demographic data and self-reported non-musculoskeletal systemic features. Correlation of GJH scores and systemic features were performed using Spearman’s rank correlation. The survey was completed by 116 individuals (95% female; 16–68 years) with 57 (93% female) also participating in the physical assessment. The most prevalent systemic feature was orthostatic intolerance (98%), followed by easy bruising and urinary incontinence (97% and 84% respectively). Of those reporting symptoms of orthostatic intolerance, easy bruising, and urinary incontinence, 58%, 40%, and 18% described them as very highly frequent respectively (frequency > 75%). No significant correlations were found between the extent of systemic features and GJH scores as measured by either the Beighton score or the LLAS. The high prevalence and frequency of the systemic features found in this study, which are omitted in diagnostic classification criteria, suggest that further research on their diagnostic accuracy is warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A (2017) A framework for the classification of joint hypermobility and related conditions. Am J Med Genet Part C Semin Med Genet 175:148–157CrossRefPubMed Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A (2017) A framework for the classification of joint hypermobility and related conditions. Am J Med Genet Part C Semin Med Genet 175:148–157CrossRefPubMed
2.
go back to reference Castori M, Colombi M (2015) Generalized joint hypermobility, joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet Part C Semin Med Genet 169:1–5CrossRef Castori M, Colombi M (2015) Generalized joint hypermobility, joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet Part C Semin Med Genet 169:1–5CrossRef
3.
go back to reference Hakim AJ (2004) Joint hypermobility. Best Pract Res Clin Rheumatol 17:989–1004CrossRef Hakim AJ (2004) Joint hypermobility. Best Pract Res Clin Rheumatol 17:989–1004CrossRef
4.
go back to reference Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27:1777–1779PubMed Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27:1777–1779PubMed
5.
go back to reference Beighton P (1998) Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet 77:31–37CrossRefPubMed Beighton P (1998) Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet 77:31–37CrossRefPubMed
6.
go back to reference Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet A 149:2368–2370CrossRef Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet A 149:2368–2370CrossRef
7.
go back to reference Castori M, Morlino S, Celletti C, Ghibellini G, Bruschini M, Grammatico P, Blundo C, Camerota F (2013) Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet A 161:2989–3004CrossRef Castori M, Morlino S, Celletti C, Ghibellini G, Bruschini M, Grammatico P, Blundo C, Camerota F (2013) Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet A 161:2989–3004CrossRef
8.
go back to reference Hakim AJ, Sahota A (2006) Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue. Clin Dermatol 24:521–533CrossRefPubMed Hakim AJ, Sahota A (2006) Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue. Clin Dermatol 24:521–533CrossRefPubMed
9.
go back to reference Castori M (2012) Ehlers-Danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations. ISRN Dermatol 2012:1–22 Castori M (2012) Ehlers-Danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations. ISRN Dermatol 2012:1–22
10.
11.
go back to reference Terry RH, Palmer ST, Rimes KA, Clark CJ, Simmonds JV, Horwood JP (2015) Living with joint hypermobility syndrome: patient experiences of diagnosis, referral and self-care. Fam Pract 32:354–358CrossRefPubMedPubMedCentral Terry RH, Palmer ST, Rimes KA, Clark CJ, Simmonds JV, Horwood JP (2015) Living with joint hypermobility syndrome: patient experiences of diagnosis, referral and self-care. Fam Pract 32:354–358CrossRefPubMedPubMedCentral
12.
go back to reference Krahe AM, Adams RD, Nicholson LL (2017) Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers–Danlos syndrome – hypermobility type. Disabil Rehabil 8288:1–8 Krahe AM, Adams RD, Nicholson LL (2017) Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers–Danlos syndrome – hypermobility type. Disabil Rehabil 8288:1–8
13.
14.
go back to reference Keer R, Butler K (2010) Physiotherapy and occupational therapy in the hypermobile adult. In: Hypermobility, fibromyalgia and chronic pain. Churchill Livingstone, Edinburgh, pp 143–161CrossRef Keer R, Butler K (2010) Physiotherapy and occupational therapy in the hypermobile adult. In: Hypermobility, fibromyalgia and chronic pain. Churchill Livingstone, Edinburgh, pp 143–161CrossRef
15.
go back to reference Palmer S, Terry R, Rimes KA, Clark C, Simmonds J, Horwood J (2016) Physiotherapy management of joint hypermobility syndrome – a focus group study of patient and health professional perspectives. Physiotherapy 102:93–102CrossRefPubMed Palmer S, Terry R, Rimes KA, Clark C, Simmonds J, Horwood J (2016) Physiotherapy management of joint hypermobility syndrome – a focus group study of patient and health professional perspectives. Physiotherapy 102:93–102CrossRefPubMed
16.
go back to reference Annemans L, Wessely S, Spaepen E, Caekelbergh K, Caubère JP, Le Lay K, Taïeb C (2008) Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum 58:895–902 Annemans L, Wessely S, Spaepen E, Caekelbergh K, Caubère JP, Le Lay K, Taïeb C (2008) Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum 58:895–902
17.
go back to reference Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, de Backer J, de Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B (2017) The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet Part C: Semin Med Genet 175:8–26CrossRef Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, de Backer J, de Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B (2017) The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet Part C: Semin Med Genet 175:8–26CrossRef
18.
go back to reference Hakim AJ, Grahame R (2004) Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction? Rheumatology 43:1194–1195CrossRefPubMed Hakim AJ, Grahame R (2004) Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction? Rheumatology 43:1194–1195CrossRefPubMed
19.
go back to reference Gazit Y, Jacob G, Grahame R (2016) Ehlers–Danlos syndrome— hypermobility type: a much neglected multisystemic disorder. Rambam Maimonides Med J 7:1–11CrossRef Gazit Y, Jacob G, Grahame R (2016) Ehlers–Danlos syndrome— hypermobility type: a much neglected multisystemic disorder. Rambam Maimonides Med J 7:1–11CrossRef
20.
go back to reference Gazit Y, Nahir AM, Grahame R, Jacob G (2003) Dysautonomia in the joint hypermobility syndrome. Am J Med 115:33–40CrossRefPubMed Gazit Y, Nahir AM, Grahame R, Jacob G (2003) Dysautonomia in the joint hypermobility syndrome. Am J Med 115:33–40CrossRefPubMed
21.
go back to reference Rombaut L, Malfait F, Cools A, De Paepe A, Calders P (2010) Musculoskeletal complaints, physical activity and health-related quality of life among patients with the Ehlers–Danlos syndrome hypermobility type. Disabil Rehabil 32:1339–1345 Rombaut L, Malfait F, Cools A, De Paepe A, Calders P (2010) Musculoskeletal complaints, physical activity and health-related quality of life among patients with the Ehlers–Danlos syndrome hypermobility type. Disabil Rehabil 32:1339–1345
22.
go back to reference Arunkalaivanan AS, Morrison A, Jha S, Blann A (2009) Prevalence of urinary and faecal incontinence among female members of the Hypermobility Syndrome Association (HMSA). J Obstet Gynaecol (Lahore) 29:126–128CrossRef Arunkalaivanan AS, Morrison A, Jha S, Blann A (2009) Prevalence of urinary and faecal incontinence among female members of the Hypermobility Syndrome Association (HMSA). J Obstet Gynaecol (Lahore) 29:126–128CrossRef
23.
go back to reference Lodish H, Berk A, Kaiser C, Krieger M, Scott MP, Bretscher A, Matsudaira P (2008) Molecular cell biology. WH Freeman, New York Lodish H, Berk A, Kaiser C, Krieger M, Scott MP, Bretscher A, Matsudaira P (2008) Molecular cell biology. WH Freeman, New York
25.
go back to reference Ferrari J, Parslow C, Lim E, Hayward A (2005) Joint hypermobility: the use of a new assessment tool to measure lower limb hypermobility. Clin Exp Rheumatol 23:413–420PubMed Ferrari J, Parslow C, Lim E, Hayward A (2005) Joint hypermobility: the use of a new assessment tool to measure lower limb hypermobility. Clin Exp Rheumatol 23:413–420PubMed
26.
go back to reference Meyer K, Chan C, Hopper L, Nicholson LL (2017) Identifying lower limb specific and generalised joint hypermobility in adults: validation of the Lower Limb Assessment Score identifying lower limb specific and generalised joint hypermobility in adults : a validation study. BMC Musculoskelet Disord 18:514CrossRefPubMedPubMedCentral Meyer K, Chan C, Hopper L, Nicholson LL (2017) Identifying lower limb specific and generalised joint hypermobility in adults: validation of the Lower Limb Assessment Score identifying lower limb specific and generalised joint hypermobility in adults : a validation study. BMC Musculoskelet Disord 18:514CrossRefPubMedPubMedCentral
27.
go back to reference Singh H, McKay M, Baldwin JN, Nicholson LL, Chan C, Burns J, Hiller CE (2017) Beighton scores and cut-offs across the lifespan: cross-sectional study of an Australian population. Rheumatology 56:1857–1864CrossRefPubMed Singh H, McKay M, Baldwin JN, Nicholson LL, Chan C, Burns J, Hiller CE (2017) Beighton scores and cut-offs across the lifespan: cross-sectional study of an Australian population. Rheumatology 56:1857–1864CrossRefPubMed
28.
go back to reference Smits-Engelsman B, Klerks M, Kirby A (2011) Beighton score: a valid measure for generalized hypermobility in children. J Pediatrics 158:119–123CrossRef Smits-Engelsman B, Klerks M, Kirby A (2011) Beighton score: a valid measure for generalized hypermobility in children. J Pediatrics 158:119–123CrossRef
29.
go back to reference Evans AM, Rome K, Peet L (2012) The foot posture index, ankle lunge test, Beighton scale and the lower limb assessment score in healthy children: a reliability study. J Foot Ankle Res 5:1CrossRefPubMedPubMedCentral Evans AM, Rome K, Peet L (2012) The foot posture index, ankle lunge test, Beighton scale and the lower limb assessment score in healthy children: a reliability study. J Foot Ankle Res 5:1CrossRefPubMedPubMedCentral
30.
go back to reference Taylor R (1990) Interpretation of the correlation coefficient: a basic review. J Diagnostic Med Sonogr 6:35–39CrossRef Taylor R (1990) Interpretation of the correlation coefficient: a basic review. J Diagnostic Med Sonogr 6:35–39CrossRef
31.
32.
go back to reference Fu Q, Arbab-Zadeh A, Perhonen MA, Zhang R, Zuckerman JH, Levine BD (2004) Hemodynamics of orthostatic intolerance: implications for gender differences. American J Physiol Heart Circ Physiol 286:H449–H457CrossRef Fu Q, Arbab-Zadeh A, Perhonen MA, Zhang R, Zuckerman JH, Levine BD (2004) Hemodynamics of orthostatic intolerance: implications for gender differences. American J Physiol Heart Circ Physiol 286:H449–H457CrossRef
33.
go back to reference Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz IJ, Schondorf R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Autonomic Neurosci: Basic Clin 161:46–48CrossRef Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz IJ, Schondorf R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Autonomic Neurosci: Basic Clin 161:46–48CrossRef
35.
go back to reference Moon J, Kim D-Y, Byun J-I, Sunwoo J-S, Lim J-A, Kim T-J, Shin JW, Lee WJ, Lee HS, Jun JS, Park KI, Jung KH, Lee ST, Jung KY, Chu K, Lee SK (2016) Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome. Health Qual Life Outcomes 14:144CrossRefPubMedPubMedCentral Moon J, Kim D-Y, Byun J-I, Sunwoo J-S, Lim J-A, Kim T-J, Shin JW, Lee WJ, Lee HS, Jun JS, Park KI, Jung KH, Lee ST, Jung KY, Chu K, Lee SK (2016) Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome. Health Qual Life Outcomes 14:144CrossRefPubMedPubMedCentral
36.
go back to reference Abrams P, Smith AP, Cotterill N (2015) The impact of urinary incontinence on health-related quality of life (HRQoL) in a real-world population of women aged 45–60 years: results from a survey in France, Germany, the UK and the USA. BJU Int 115:143–152CrossRefPubMed Abrams P, Smith AP, Cotterill N (2015) The impact of urinary incontinence on health-related quality of life (HRQoL) in a real-world population of women aged 45–60 years: results from a survey in France, Germany, the UK and the USA. BJU Int 115:143–152CrossRefPubMed
37.
go back to reference Bedretdinova D, Fritel X, Zins M, Ringa V (2006) The effect of urinary incontinence on health-related quality of life: is it similar in men and women? Urology 91:83–89CrossRef Bedretdinova D, Fritel X, Zins M, Ringa V (2006) The effect of urinary incontinence on health-related quality of life: is it similar in men and women? Urology 91:83–89CrossRef
38.
go back to reference Hawthorne G (2006) Measuring incontinence in Australia. Commonwealth of Australia, Canberra Hawthorne G (2006) Measuring incontinence in Australia. Commonwealth of Australia, Canberra
39.
go back to reference McIntosh LJ, Mallett VT, Frahm JD, Richardson DA, Evans MI (1995) Gynecologic disorders in women with Ehlers-Danlos syndrome. J Soc Gynecol Investig 2:559–564CrossRefPubMed McIntosh LJ, Mallett VT, Frahm JD, Richardson DA, Evans MI (1995) Gynecologic disorders in women with Ehlers-Danlos syndrome. J Soc Gynecol Investig 2:559–564CrossRefPubMed
40.
go back to reference Veit-Rubin N, Cartwright R, Singh AU, Digesu GA, Fernando R, Khullar V (2016) Association between joint hypermobility and pelvic organ prolapse in women: a systematic review and meta-analysis. Int Urogynecol J 27:1469–1478CrossRefPubMed Veit-Rubin N, Cartwright R, Singh AU, Digesu GA, Fernando R, Khullar V (2016) Association between joint hypermobility and pelvic organ prolapse in women: a systematic review and meta-analysis. Int Urogynecol J 27:1469–1478CrossRefPubMed
41.
go back to reference De Paepe A, Malfait F (2004) Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol 127:491–500CrossRefPubMed De Paepe A, Malfait F (2004) Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol 127:491–500CrossRefPubMed
42.
go back to reference Simmons LA, Wolever RQ, Bechard EM, Snyderman R (2014) Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease. Genome Med 6:16CrossRefPubMedPubMedCentral Simmons LA, Wolever RQ, Bechard EM, Snyderman R (2014) Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease. Genome Med 6:16CrossRefPubMedPubMedCentral
43.
go back to reference Stine KC, Becton DL (1997) DDAVP therapy controls bleeding in Ehlers–Danlos syndrome. J Pediatr Hematol Oncol 19:156–158CrossRefPubMed Stine KC, Becton DL (1997) DDAVP therapy controls bleeding in Ehlers–Danlos syndrome. J Pediatr Hematol Oncol 19:156–158CrossRefPubMed
44.
go back to reference Clinch J, Deere K, Sayers A, Palmer S, Riddoch C, Tobias JH, Clark EM (2011) Epidemiology of generalized joint laxity (hypermobility) in fourteen-year-old children from the UK: a population-based evaluation. Arthritis Rheum 63:2819–2827CrossRefPubMedPubMedCentral Clinch J, Deere K, Sayers A, Palmer S, Riddoch C, Tobias JH, Clark EM (2011) Epidemiology of generalized joint laxity (hypermobility) in fourteen-year-old children from the UK: a population-based evaluation. Arthritis Rheum 63:2819–2827CrossRefPubMedPubMedCentral
45.
go back to reference Nicholson LL, Chan C (2018) The Upper Limb Hypermobility Assessment Tool: a novel validated measure of adult joint mobility. Musculoskelet Sci Pract 35:38–45CrossRefPubMed Nicholson LL, Chan C (2018) The Upper Limb Hypermobility Assessment Tool: a novel validated measure of adult joint mobility. Musculoskelet Sci Pract 35:38–45CrossRefPubMed
Metadata
Title
Prevalence and frequency of self-perceived systemic features in people with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type
Authors
Cliffton Chan
Anne Krahe
Yim Tang Lee
Leslie L. Nicholson
Publication date
01-02-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4296-7

Other articles of this Issue 2/2019

Clinical Rheumatology 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.